Intermolecular Inc. Hits New 52-Week Low at $5.41 (IMI)
Shares of Intermolecular (NYSE:IMI) hit a new 52-week low during mid-day trading on Wednesday, American Banking and Market News reports. The stock traded as low as $5.41 and last traded at $5.63, with a volume of 131,885 shares trading hands. The stock had previously closed at $5.57.
A number of analysts have recently weighed in on IMI shares. Analysts at Needham & Company cut their price target on shares of Intermolecular (NYSE:IMI) from $12.00 to $10.00 in a research note to investors on Friday, July 26th. They now have a “buy” rating on the stock. Separately, analysts at JPMorgan Chase & Co. downgraded shares of Intermolecular (NYSE:IMI) to a “neutral” rating in a research note to investors on Wednesday, July 10th. Finally, analysts at JPMorgan Chase & Co. downgraded shares of Intermolecular (NYSE:IMI) from an “overweight” rating to a “neutral” rating in a research note to investors on Wednesday, July 10th. They now have a $12.00 price target on the stock, down previously from $15.00.
Intermolecular has a one year low of $5.46 and a one year high of $10.69. The stock’s 50-day moving average is $5.87 and its 200-day moving average is $7.54. The company’s market cap is $258.7 million.
Intermolecular (NYSE:IMI) last released its earnings data on Thursday, July 25th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.02. The company had revenue of $16.60 million for the quarter, compared to the consensus estimate of $16.54 million. During the same quarter in the previous year, the company posted ($0.02) earnings per share. The company’s revenue for the quarter was up .6% on a year-over-year basis. On average, analysts predict that Intermolecular will post $-0.01 earnings per share for the current fiscal year.
Intermolecular, Inc (NYSE:IMI) is engaged in research and development and time-to-market for the semiconductor and clean-energy industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.